EA201891431A1 - Способы получения замещенного 5,6-дигидро-6- фенилбензо[f]изохинолин-2-амина - Google Patents

Способы получения замещенного 5,6-дигидро-6- фенилбензо[f]изохинолин-2-амина

Info

Publication number
EA201891431A1
EA201891431A1 EA201891431A EA201891431A EA201891431A1 EA 201891431 A1 EA201891431 A1 EA 201891431A1 EA 201891431 A EA201891431 A EA 201891431A EA 201891431 A EA201891431 A EA 201891431A EA 201891431 A1 EA201891431 A1 EA 201891431A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
phenilbenzo
izohinolin
dihydro
amine
Prior art date
Application number
EA201891431A
Other languages
English (en)
Russian (ru)
Inventor
Крейг Бэйтс
Дэвид П. Рид
Цзяньминь Мао
Original Assignee
Аркьюл, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аркьюл, Инк. filed Critical Аркьюл, Инк.
Publication of EA201891431A1 publication Critical patent/EA201891431A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EA201891431A 2015-12-17 2016-12-16 Способы получения замещенного 5,6-дигидро-6- фенилбензо[f]изохинолин-2-амина EA201891431A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562268758P 2015-12-17 2015-12-17
PCT/US2016/067161 WO2017106639A1 (en) 2015-12-17 2016-12-16 Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine

Publications (1)

Publication Number Publication Date
EA201891431A1 true EA201891431A1 (ru) 2018-11-30

Family

ID=59057623

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891431A EA201891431A1 (ru) 2015-12-17 2016-12-16 Способы получения замещенного 5,6-дигидро-6- фенилбензо[f]изохинолин-2-амина

Country Status (16)

Country Link
US (4) US9834519B2 (https=)
EP (2) EP3390368A4 (https=)
JP (2) JP6940504B2 (https=)
KR (1) KR20180085814A (https=)
CN (2) CN114874149A (https=)
AU (2) AU2016369520B2 (https=)
BR (1) BR112018012325A2 (https=)
CA (1) CA3006077A1 (https=)
EA (1) EA201891431A1 (https=)
HK (1) HK1255014A1 (https=)
IL (1) IL259557A (https=)
MX (2) MX2020012771A (https=)
NZ (1) NZ742785A (https=)
SG (1) SG11201804601TA (https=)
TW (1) TWI748972B (https=)
WO (1) WO2017106639A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3006077A1 (en) 2015-12-17 2017-06-22 Arqule, Inc. Methods for preparing polymorphs of substituted 5,6-dihydrobenzo[h]quinazolin-2-amine
IL259556B2 (en) * 2015-12-17 2023-09-01 Arqule Inc Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds
CN110669015A (zh) * 2018-07-03 2020-01-10 上海喀露蓝科技有限公司 一种fgfr抑制剂的制备方法
US10878412B2 (en) * 2019-05-13 2020-12-29 Truist Bank In-line verification of transactions
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP0946523A1 (en) * 1996-12-23 1999-10-06 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
EP1831207B1 (en) 2004-12-17 2012-11-14 Amgen Inc. Aminopyrimidine compounds as plk inhibitors
JP2010514810A (ja) 2006-12-29 2010-05-06 ライジェル ファーマシューティカルズ, インコーポレイテッド Axlインヒビターとして有用な置換トリアゾール
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
TWI461410B (zh) * 2008-12-30 2014-11-21 Arqule Inc 經取代之5,6-二氫-6-苯基苯並〔f〕異喹啉-2-胺化合物類
US9012464B2 (en) 2010-11-25 2015-04-21 Ratiopharm Gmbh Salts and polymorphic forms of Afatinib
WO2012177852A1 (en) * 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
CN106459993A (zh) * 2014-03-31 2017-02-22 德彪药业国际股份公司 Fgfr融合体
CA3006077A1 (en) * 2015-12-17 2017-06-22 Arqule, Inc. Methods for preparing polymorphs of substituted 5,6-dihydrobenzo[h]quinazolin-2-amine
IL259556B2 (en) 2015-12-17 2023-09-01 Arqule Inc Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds

Also Published As

Publication number Publication date
US20180065937A1 (en) 2018-03-08
BR112018012325A2 (pt) 2018-12-04
WO2017106639A1 (en) 2017-06-22
JP6940504B2 (ja) 2021-09-29
SG11201804601TA (en) 2018-07-30
US20170174637A1 (en) 2017-06-22
US10093632B2 (en) 2018-10-09
IL259557A (en) 2018-07-31
NZ742785A (en) 2023-06-30
US20200102276A1 (en) 2020-04-02
HK1255014A1 (zh) 2019-08-02
US11279679B2 (en) 2022-03-22
EP3390368A4 (en) 2019-07-03
US9834519B2 (en) 2017-12-05
MX2020012771A (es) 2022-10-04
KR20180085814A (ko) 2018-07-27
US20190241527A1 (en) 2019-08-08
TWI748972B (zh) 2021-12-11
MX2018007415A (es) 2018-11-09
MX385672B (es) 2025-03-18
AU2021202610B2 (en) 2022-06-02
EP3390368A1 (en) 2018-10-24
JP2018537495A (ja) 2018-12-20
CA3006077A1 (en) 2017-06-22
US10766868B2 (en) 2020-09-08
AU2016369520B2 (en) 2021-02-18
AU2016369520A1 (en) 2018-06-07
CN108602779A (zh) 2018-09-28
TW201733992A (zh) 2017-10-01
JP2021191782A (ja) 2021-12-16
EP4015508A1 (en) 2022-06-22
AU2021202610A1 (en) 2021-05-27
CN114874149A (zh) 2022-08-09

Similar Documents

Publication Publication Date Title
EA201692219A1 (ru) Способы получения противовирусных соединений
EA201890752A1 (ru) Способ получения противогрибковых соединений
EA201792535A1 (ru) Гетероциклические амиды в качестве ингибиторов киназ
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
EA201790407A1 (ru) Зонды для визуализации белка хантингтина
EA201691649A1 (ru) Способ получения противогрибковых соединений
PE20160862A1 (es) Polimorfo de los inhibidores de la syk
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
EA201890899A1 (ru) Модуляторы фарнезоидного x-рецептора
EA201792067A1 (ru) Противогрибковые соединения и способы получения
EA201691648A1 (ru) Способ получения противогрибковых соединений
IL260730B (en) Process for preparing terpinene-4-ol
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
MX387796B (es) Compuestos de aminocarbonilcarbamato.
IL269626A (en) Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2
EA201790400A1 (ru) Зонды для визуализации белка хантингтина
EA201891431A1 (ru) Способы получения замещенного 5,6-дигидро-6- фенилбензо[f]изохинолин-2-амина
BR112016029510A2 (pt) métodos para a preparação de um composto, e, composto intermediário.
IL255625B (en) Salts and prodrugs of 1-methyl-d-tryptophan
HUE054815T2 (hu) 3,5-Difenil-diazol vegyületek vízoldható származékai
EA201791645A1 (ru) Новые соли и полиморфы scy-078
EA201690294A1 (ru) Новые соединения и их применение для получения tau-визуализирующих агентов и tau-визуализирующих составов
HUE055374T2 (hu) Eljárás Lenvatinib elõállítására
MX384260B (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.